Navigation Links
Women's Testosterone Patch May Not Work
Date:3/2/2009

U.K. study also questions safety of drug Intrinsa used for sexual dysfunction

MONDAY, March 2 (HealthDay News) -- A new testosterone patch designed to boost a woman's sex drive may be ineffective, and questions remain about its long-term safety, according to the journal Drugs and Therapeutics Bulletin.

The drug Intrinsa was recently approved in the United Kingdom for treatment of women who've gone through menopause as the result of ovary and womb removal and who are receiving estrogen replacement therapy. There is some evidence that low levels of circulating testosterone may be linked to a decline in sex drive after menopause.

The patch, which is placed on the lower abdomen and delivers a daily dose of testosterone, is worn constantly and replaced twice weekly.

The journal noted, in finding that the patch may not work, that key clinical trials on testosterone patches involved highly selective groups of women. For example, the studies excluded those with various mental or physical conditions that could affect sex drive. In some trials, a hypoactive sexual desire disorder (HSDD) diagnosis was based on short, unvalidated questionnaires filled out by participants, the journal reported.

There were other problems with the studies:

  • There was a large placebo response. Significant numbers of women not treated with the patch reported improved sex drive, which suggests that low testosterone levels may not have been the problem.
  • Improvements in sex drive were small.
  • Many women were already having sex two or three times a month before they entered the trials, which raises questions about whether they really had poor sex drive in the first place.
  • The trials for Intrinsa lasted a maximum of six months, which means they didn't demonstrate the long-term safety of the patch.
  • Rates of side effects in the two key trials were around 75 percent. These included skin reactions at sites where the patches were applied, acne, excess hair, hair loss, breast pain, weight gain, insomnia , voice deepening, and migraine.

"The published evidence so far is based on highly selected women and only shows small improvements in sexual parameters and large placebo responses," according to the journal. "Also, the long-term safety of the treatment is unknown. Unwanted side effects are common and not always reversible. For all these reasons, we cannot recommend Intrinsa for use in women with sexual dysfunction."

More information

The National Women's Health Information Center has more about sexual health.



-- Robert Preidt



SOURCE: BMJ specialist journals, news release, March 3, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Womenshealthchannel Enhancements Support Pregnant Teens
2. Prostate cancer drug reduces testosterone levels in as little as 3 days
3. Study shows testosterone improves sexual well-being in post-menopausal women
4. Testosterone Patch Restores Libido in Postmenopausal Women
5. Testosterone key to disease transmission
6. AUDIO from Medialink and Solvay: Men Suffering From Symptoms of Low Testosterone Should Talk to Their Doctor
7. Studies Support Testosterone Supplements for Older Men
8. Gamma Labs to Boost Testosterone At World Series of Poker In Las Vegas
9. Men With Low Testosterone Not Receiving Treatment
10. Many men with low testosterone levels do not receive treatment
11. Testosterone Spray Improves Sexual Satisfaction in Women
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Women's Testosterone Patch May Not Work
(Date:4/24/2017)... Raton, Florida (PRWEB) , ... April 24, 2017 , ... ... chai teas, announced its products are now available for purchase on RevNutrition.com, a popular ... form of tea first produced and popularized in ancient India and Siam. It spread ...
(Date:4/24/2017)... NEW PORT RICHEY, Fla. (PRWEB) , ... April ... ... Disease Control and Prevention (CDC), rising prescription opioid overdose deaths now claim the ... (DEA) has slashed its civil case filings against drug manufacturers, distributors, pharmacies and ...
(Date:4/24/2017)... ... , ... Rod Burkett, CEO of Gardant Management Solutions, was recently featured in ... the forefront of Gardant since it was founded in 1999. His drive and inquisitive ... more than 40 new senior living communities. With his leadership, Gardant has grown to ...
(Date:4/24/2017)... ... ... Come to PAINWeekEnd (PWE) Tampa on May 20 and 21, at the ... 2-day program. , An attendee at a recent PAINWeekEnd said, "Very helpful, wish ... course entitled Ain't Misbehavin': Decreasing and Managing Pain Patient Aberrant Behavior, presented by Dr. ...
(Date:4/24/2017)... ... April 24, 2017 , ... A new global study of ... student well-being has seriously declined. "When disenfranchised youth from the heart of our ... State to turn the historic multi-ethnic and multi-religious powerhouses of the Middle East ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... MINNEAPOLIS , April 20, 2017  Cogentix ... company focused on providing the Urology, Uro/Gyn and ... reported that Ash Keswani has joined the Company ... In this newly created position, Mr. Keswani will ... and CEO. "Our organization is delighted ...
(Date:4/20/2017)... April 20, 2017 Research and ... Biosimilar Pipeline and Market Prospects: Addressing Production Complexities Through ... their offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming Production ... an in-depth assessment of the current trends in the ...
(Date:4/20/2017)... 20, 2017  CVS Pharmacy, the retail division ... new store design to enhance the retail customer ... health-focused products and expanded beauty selections paired with ... discover new offerings. Together with its innovative digital ... the customer experience at CVS Pharmacy.  ...
Breaking Medicine Technology: